Companies

Fresenius makes delisting offer; to buy shares for Rs 390 cr

PTI New Delhi | Updated on September 16, 2013 Published on September 16, 2013

Promoters of healthcare services firm Fresenius Kabi Oncology today made a delisting offer to acquire all publicly held shares for about Rs 390 crore — culminating a long running dispute with market regulator SEBI.

Under the delisting offer of more that three crore shares, accounting for 19 per cent stake in the company, will be acquired at an indicative offer price of Rs 130 each.

“Through the delisting offer, the acquirer seeks to acquire up to 30,063,255 shares of the company representing 19 per cent of the total share capital of the company from the public shareholders,” Fresenius Kabi said in a public announcement today.

The delisting offer would commence on October 15 and close on October 22, 2013, the company said.

DSP Merill Lynch is the manager, while Link Intime is the registrar, to the delisting offer.

As per norms, a delisting offer is considered successful if the post-offer shareholding of promoters crosses the higher of 90 percent of the company’s total share capital, or the aggregate percentage of pre-offer promoter shareholding and 50 per cent of the offer size.

In end to a long-standing dispute, Fresenius Kabi had got SEBI’s permission to delist its shares from the stock market, in July, this year.

The regulator had said that the company would have to take into account its pre-OFS (Offer for Sale) promoter shareholding of 90 per cent instead of 81 per cent holding achieved after the OFS to determine the minimum number of shares to be acquired for the delisting.

However, last week, the Securities Appellate Tribunal had allowed the healthcare firm to delist its shares without any such conditions.



Published on September 16, 2013

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.